Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - GROSS PROFIT
Gross Profit URGN - UroGen Pharma Ltd.
73.4 M
LAST VALUE
30.78%
2 YEAR CAGR
156.33%
5 YEAR CAGR
0.00%
10 YEAR CAGR